Medgenics, Inc. (OTC:MEDG) has announced that Joel Kanter has acquired 25,000 common shares of the company’s common stock. The shares were valued at USD 0.0001 per share. Mr. Kanter and his related parties now hold 14,078,3997 common shares giving him a total of 11.5% of the company’s share capital.
MicroCap Insider is a web-based financial portal.
Sign Up for our Free Stock Newsletter
MicroCap Insider publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors.
Medgenics, Inc. is a holding company engaged in the research and development of products for the biotechnology and associated medial equipment fields. It’s wholly owned subsidiary is Medgenics Medical Israel Ltd. The company’s current technology platform has the potential to treat a variety of therapeutic areas including diabetes, arthritis, wound healing, obesity, chronic pain, and cancer recovery.
Sign Up for FREE. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website.
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer.
